Allen Operations LLC Takes $3.83 Million Position in Tempus AI, Inc. (NASDAQ:TEM)

Allen Operations LLC bought a new position in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 109,459 shares of the company's stock, valued at approximately $3,831,000. Tempus AI makes up 0.7% of Allen Operations LLC's portfolio, making the stock its 20th largest position. Allen Operations LLC owned 0.07% of Tempus AI at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. EFG Asset Management North America Corp. purchased a new position in Tempus AI during the second quarter valued at approximately $1,333,000. Alphabet Inc. purchased a new position in shares of Tempus AI during the 2nd quarter valued at $54,289,000. Pier Capital LLC purchased a new position in shares of Tempus AI during the 2nd quarter valued at $2,301,000. Revolution Growth Management Company Inc. bought a new position in shares of Tempus AI in the second quarter worth $128,133,000. Finally, Federated Hermes Inc. purchased a new stake in shares of Tempus AI in the second quarter worth $19,886,000.

Tempus AI Stock Up 8.6 %

NASDAQ:TEM traded up $3.93 during trading hours on Friday, reaching $49.38. The company's stock had a trading volume of 929,541 shares, compared to its average volume of 1,221,280. The firm's 50-day moving average price is $46.78. Tempus AI, Inc. has a 1 year low of $22.89 and a 1 year high of $77.00.

Tempus AI (NASDAQ:TEM - Get Free Report) last announced its quarterly earnings data on Tuesday, August 6th. The company reported ($6.77) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($4.41) by ($2.36). The firm had revenue of $165.97 million during the quarter, compared to analysts' expectations of $159.10 million. Sell-side analysts anticipate that Tempus AI, Inc. will post -6.51 EPS for the current year.

Analyst Ratings Changes

TEM has been the subject of several recent analyst reports. William Blair began coverage on Tempus AI in a research report on Tuesday, July 9th. They set an "outperform" rating for the company. Piper Sandler began coverage on shares of Tempus AI in a research report on Monday, August 12th. They issued a "neutral" rating and a $40.00 price objective on the stock. JPMorgan Chase & Co. lifted their target price on shares of Tempus AI from $42.00 to $47.00 and gave the company an "overweight" rating in a research report on Wednesday, August 7th. Stifel Nicolaus began coverage on shares of Tempus AI in a report on Tuesday, July 9th. They issued a "buy" rating and a $45.00 price target on the stock. Finally, TD Cowen started coverage on shares of Tempus AI in a research report on Tuesday, July 9th. They set a "buy" rating and a $50.00 price objective on the stock. One analyst has rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat.com, Tempus AI presently has an average rating of "Moderate Buy" and a consensus target price of $45.56.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.